DNA and protein HIV vaccines: how should we mix it? | Lancet HIV;11(5): e274-e275, 2024 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

DNA and protein HIV vaccines: how should we mix it?

Levy, Yves.

Affiliation

Levy Y; Groupe Henri-Mondor Albert-Chenevier, AP-HP, Créteil, France; Vaccine Research Institute, INSERM U955, Université Paris-Est Créteil, 94010 Créteil, France. Electronic address: yves.levy@aphp.fr.

Lancet HIV ; 11(5): e274-e275, 2024 May.

Article in En | MEDLINE | ID: mdl-38692821

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / AIDS Vaccines / Vaccines, DNA Limits: Humans Language: En Journal: Lancet HIV Year: 2024 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / AIDS Vaccines / Vaccines, DNA Limits: Humans Language: En Journal: Lancet HIV Year: 2024 Document type: Article